Synbio Technologies's Gene Delivery Services Accelerate the Process...

Pharma Tech Outlook: Pharma Tech Magazine

Synbio Technologies's Gene Delivery Services Accelerate the Process of Gene Therapy

By Pharma Tech Outlook | Friday, October 16, 2020

Synbio Technologies, a leading DNA technology company, has launched gene therapy services.

What is Gene Therapy?

Gene therapy is the administration of genetic material to modify or manipulate the expression of a gene product or to alter the biological properties of living cells for therapeutic use. Gene therapy is mainly used to treat some serious diseases that are a threat to human health, such as hemophilia, malignant tumors, cardiovascular diseases, infectious diseases, and so on. Treating diseases with gene therapy can be achieved by three approaches: (1) replacing a disease-causing gene with a healthy copy of the gene, (2) inactivating a disease-causing gene that is not functioning properly, and (3) introducing a new or modified gene into the body to help treat a disease. The target cells of gene therapy can be divided into two categories: somatic cells and germ cells. When a functional gene is created, it needs a suitable vector to deliver the gene to the target cell. In this process, the commonly used vectors are divided into viral (e.g. adeno-associated virus, adenovirus, lentivirus) or non-viral(e.g. naked DNA, plasmid DNA, liposome) genetic engineering vectors.Viral vectors have become the most commonly used and most extensively safety testedtherapeutic genecarrier in clinical research because of their natural ability to invade target cells and transfer new genes. It has become an essential research project for gene therapy to develop safer, effective, and efficient expression vectors.

Gene Therapy Services

Synbio Technologies is a leading expert in gene synthesis, gene construction, gene expression, gene editing,and virus packaging for gene delivery and gene therapy applications. Synbio Technologies has launched several gene therapy services, including adeno-associated virus (AAV) gene delivery, adenovirus gene delivery, and lentivirus gene delivery. Syno®viral gene delivery services provide one-stop solutions from upstream gene synthesis to gene delivery with variable choices: ready-to-use sgRNA, purified functional proteins, and high quality ready-to-use viruses. Our gene delivery services offer different scales to meet our customers’ needs, ranging from small-scale virus packaging for in vitro work, to large-scale virus packaging for animal studies, to virus GMP production for use in clinical applications. Our gene synthesis, gene construction, and gene delivery platforms also providegene delivery with variable virus packaging forms, including AAV, adenovirus, and lentivirus packaging services.

• High Quality: We guarantee 100% accuracy on all delivered gene products with stringent quality control.

• One-Stop Services: Our Syno®viral gene delivery services provide one-stop high quality services from gene synthesis to virus packaging to save your time, labor, and money without physically preparing anything by yourself.

• Competitive Price: The whole package of one-stop services from gene synthesis, gene construction, to virus packaging starts as low as $1,900 for AAV gene delivery, $950 for adenovirus gene delivery, and $950 for lentivirus gene delivery.

• Technical Support: Professional team extensively experienced in long gene synthesis and virus production is here to support your research.

Weekly Brief

Read Also